4 results  1 of 1 

1 Downregulation of IL-18 Expression in the Gut by Metformin-induced Gut Microbiota Modulation
Heetae Lee, Jiyeon Kim, Jinho An, Sungwon Lee, Dohyun Choi, Hyunseok Kong, Youngcheon Song, Il Ho Park, Chong-Kil Lee, Kyungjae Kim
Immune Netw.2019;19(4):e28.  Published online 2019 August 21     DOI: http://dx.doi.org/10.4110/in.2019.19.e28
      
2 Clinical Efficacy of Glucagon Like Peptide-1 (GLP-1) Analogues
Hyun-Ji Chun, Hyuk-Sang Kwon
J Korean Diabetes.2013;14(3):125-127.   Published online 2013 January 10     DOI: http://dx.doi.org/10.4093/jkd.2013.14.3.125
   
3 Incretin-based Combination Therapy in Type 2 Diabetes Mellitus
Jae Hyeon Kim, Myung-Shik Lee
J Korean Med Assoc.2009;52(10):1030-1036.   Published online 2009 October 31     DOI: http://dx.doi.org/10.5124/jkma.2009.52.10.1030
      
4 Protective Effects of Glucagon Like Peptide-1 on HIT-T15 β Cell Apoptosis via ER Stress Induced by 2-deoxy-D-glucose
Ju-Young Kim, Seong-Kyu Lee, Haing-Woon Baik, Ki-Ho Lee, Hyun-Jin Kim, Kang-Seo Park, Byung-Joon Kim
Korean Diabetes J.2008;32(6):477-487.   Published online 2008 December 31     DOI: http://dx.doi.org/10.4093/kdj.2008.32.6.477
      

 1 of 1